In Africa, lack of awareness and low index of suspicion of rare diseases like dystrophinopathies, directly or indirectly, contributes to the increased morbidity and mortality. Therefore, even though the data on prevalence is limited, we need to have a high degree of suspicion in patients presenting with suggestive clinical features.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752564 | PMC |
http://dx.doi.org/10.1002/ccr3.3254 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!